Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)

NCT07224698 is registered in ClinicalTrials.gov with Multidisciplinary Association for Psychedelic Studies as lead sponsor.

NCT NCT07224698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)
Lead sponsor
Multidisciplinary Association for Psychedelic Studies
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 28, 2027
Completion date
December 30, 2028
Enrollment
320 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder ptsd